US Stocks
/
Certara, Inc. Share Price

Certara, Inc. Share Price

NASDAQ: CERT | Small Cap
$8.19
+$0.06 (0.80%) Last updated on 08 Aug, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Certara, Inc. Stock Performance

Open
$8.19
Prev. Close
$8.13
Circuit Range
N/A
Day Range
$8.06 - $8.29
Year Range
$4.45 - $13.88
Volume
1,91,973
Average Traded
$8.19

Certara, Inc. Share Price Today

As of 10 August 2026, Certara, Inc.'s share price is $8.19. The stock opened at $8.19, compared to its previous close of $8.13. During today's trading session, Certara, Inc.'s share price traded between $8.06 and $8.29, with an average price of $8.17. Over the past 52 weeks, the stock has recorded a high of $13.88 and a low of $4.45. In terms of performance, Certara, Inc.'s share price has risen by 15.51% over the last six months and is down 24.45% on a year-on-year basis.

Certara, Inc. Share Price Chart

$8.06$8.29
L
Show Current Price
H

Certara, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.31B
PE Ratio (TTM)
-819.00
Dividend Yield
N/A
EPS (TTM)
$-0.01
Revenue (TTM)
$418.84M
Return On Equity (TTM)
-0.15%
Profit Margin
-0.38%
Debt to Equity
0.14
Quarterly Earnings Growth YoY
211.23%

Certara, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
Revenue-$39.26M-$39.81M-$37.19M-$41.52M-$40.72M-$39.72M
Net Profit-$4.68M-$12.57M-$1.37M$4.74M-$1.97M$1.52M
Net Profit Margin11.93%31.59%3.69%-11.42%4.83%-3.84%
Income ChangeN/A-168.50%89.10%445.95%-141.49%177.49%

Certara, Inc. Annual Profit & Loss

All figures in USD

Particulars202220242025
Revenue$335.64M-$154.52M-$161.13M
Net Profit$14.73M-$12.05M-$1.59M
Net Profit Margin4.39%7.80%0.99%
Income ChangeN/A-181.81%86.76%

About Certara, Inc.

Certara, Inc., together with its subsidiaries, provides technology-enabled services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes. The company also provides Phoenix WinNonlin, a platform for non-compartmental analysis; Phoenix Hosted, which offers a secured and validated Certara Amazon Web Services workspace; Phoenix NLME, a population modeling and simulation software; and Pirana Modeling Workbench, which provides modelers with a structure to facilitate the iterative processes. In addition, it offers Chemaxon JChem engines, a chemical search engine; Chemaxon Compound Registration, which supports a streamlined lead optimization process workflow; Chemaxon Design Hub, a design and tracking platform for drug discovery teams and their external collaborators; Certara D360 software, a scientific informatics system for small molecule and biologics discovery research; and Chemaxon Marvin, a chemical drawing tool. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange to define data standards and specifications; Metadata Repository that enables study design using controlled and standardized data; CoAuthor software, which creates and assembles regulatory submissions and medical publications; and GlobalSubmit, a submissions management software. Certara Inc. was founded in 2008 and is headquartered in Radnor, Pennsylvania.

Certara, Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$8.34
$8.19
+0.99%
Jul 2026
$6.86
$8.11
+24.18%
Jun 2026
$5.83
$6.53
+12.30%
May 2026
$6.13
$5.82
-5.14%
Apr 2026
$5.77
$6.13
+7.73%
Mar 2026
$6.96
$5.69
-19.75%
Feb 2026
$8.71
$7.09
-19.39%
Jan 2026
$8.97
$8.79
-0.11%
Dec 2025
$8.97
$8.80
-3.77%
Nov 2025
$11.62
$9.15
-21.36%
Oct 2025
$12.25
$11.63
-4.83%
Sep 2025
$10.64
$12.22
+12.78%

CERT Share Price FAQs

What is Certara, Inc. share price today?

chevron-up
Certara, Inc. share price today is $8.19 as on August 8, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Certara, Inc. stock?

chevron-up
The 52 week high of Certara, Inc. stock is $13.88, while the 52 week low is $4.45 as of 8 Aug '26.

What is CERT's market capitalisation today?

chevron-up
CERT market capitalisation is $1.31B as of August 10, 2026, at 6:40 am IST.

What is CERT's net income for the last quarter?

chevron-up
CERT's net income for the last quarter is 0.00B USD.

What is the 5 year returns of CERT?

chevron-up
The 5 year returns of CERT is -75.58% as on 8 Aug '26.

What is the high & low stock price of CERT today?

chevron-up
CERT stock price hit a high of $8.29 and low of $8.06 as of 8 Aug '26.

Can I buy CERT shares in India?

chevron-up
Yes. You can buy CERT in India by opening an international trading account.